Notable companies
The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), ConocoPhillips (NYSE:COP), BHP Group Limited (NYSE:BHP), AT&T (NYSE:T), BP plc (NYSE:BP), Boeing Company (NYSE:BA), Shopify (NYSE:SHOP), Canadian Natural Resources Limited (NYSE:CNQ), Allergan plc (NYSE:AGN).
Industry description
The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Developed Ex-U.S. BMI Index.
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is a float-adjusted market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in developed countries outside the United States.
Market Cap
The average market capitalization across the SPDR® Portfolio Developed Wld ex-US ETF ETF is 21.06B. The market cap for tickers in the group ranges from 59.62 to 380.18B. ASML holds the highest valuation in this group at 380.18B. The lowest valued company is KRNT at 59.62.
High and low price notable news
The average weekly price growth across all stocks in the SPDR® Portfolio Developed Wld ex-US ETF ETF was -2%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -3%. GNS experienced the highest price growth at 64%, while EBS experienced the biggest fall at -34%.
Volume
The average weekly volume growth across all stocks in the SPDR® Portfolio Developed Wld ex-US ETF ETF was 4%. For the same stocks of the ETF, the average monthly volume growth was 27% and the average quarterly volume growth was 20%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 54
P/E Growth Rating: 57
Price Growth Rating: 53
SMR Rating: 69
Profit Risk Rating: 64
Seasonality Score: 27 (-100 ... +100)